Biotech

All Articles

Merck pays $700M for bispecific, snooping autoimmune position and also opportunity to challenge Amgen in cancer cells

.Merck &amp Co. is spending $700 million in advance to test Amgen in a blood cancer market. The offe...

Gilead pays out J&ampJ $320M to exit licensing package for seladelpar

.Along With Gilead Sciences on the verge of an FDA choice for its liver illness drug seladelpar, the...

' All palms on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can see the providers establishing outdoors tents at basecamp b...

Entero giving up team, vacating office and also pausing R&ampD

.Cushion Liquidators has turned Entero Rehabs white colored as a sheet. The lender purchased Entero ...

Exelixis falls ADC after deciding it is actually no match for Tivdak

.Exelixis is actually giving up on its own cells variable (TF)- targeting antibody-drug conjugate af...

Relay dislikes SHP2 prevention after Genentech leaves

.Three weeks after Roche's Genentech unit ignored an SHP2 inhibitor treaty, Relay Therapeutics has a...

Stoke's Dravet syndrome med discharged of predisposed medical grip

.Stoke Therapeutics' Dravet syndrome drug has been devoid of a predisposed grip, removing the method...

Fierce Biotech's Gabrielle Masson presents Tough 15 at NYSE

.Ferocious Biotech Colleague Publisher Gabrielle Masson provided the 2024 class of Intense 15 champi...

Daiichi pays for Merck $170M to develop lung cancer T-cell engager deal

.Merck &amp Co. has rapidly recovered a number of the costs of its own Javelin Therapeutics acquisti...

BioMarin standstills preclinical genetics treatment for heart disease

.After BioMarin administered a springtime tidy of its own pipeline in April, the business has actual...